Showing 1 - 10 of 22
Published on 31/10/2024
» Bangkok, Thailand – The Embassy of Switzerland in Thailand, led by Mr. Pedro Zwahlen, the Ambassador of Switzerland to Thailand, Cambodia, and Lao PDR, along with Novartis (Thailand) Limited, hosted the second forum under the theme Cardio Catalyst: Driving Change in Heart Health, reaffirming the commitment to improving the quality of cardiovascular care and promoting the health and well-being of Thai citizens. The event was honoured by the presence of H.E. Somsak Thepsuthin, Minister of Public Health of Thailand, and Kevin Zou, Head of the Asia Aspiring Cluster at Novartis International, at the Residence of the Swiss Ambassador.
Published on 18/09/2024
» King Chulalongkorn Memorial Hospital has reached a historic milestone, becoming the first hospital in Thailand to receive the prestigious American Heart Association’s Get With The Guidelines for Heart Failure (AHA GWTG HF) Gold Award. This accolade recognises the hospital’s unwavering commitment to providing world-class cardiac care, particularly for patients with heart failure, by adhering to rigorous international standards. The award not only reflects the hospital's dedication to elevating patient care but also establishes a new benchmark for excellence in cardiovascular health across the nation.
Published on 08/04/2024
» For far too long organisations have taken a one-size-fits-all approach to managing their talent. The traditional approach is to hire people for a specific role, and then train employees to fulfil that role as replacement or spare parts for a machine.
Published on 01/02/2024
» Bayer Thai Co., Ltd. announces the appointment of Bradley Williams as the Managing Director and Country Division Head of Pharmaceuticals, effective from February 1, 2024. With over 26 years of distinguished experience in the healthcare and pharmaceutical industry, Bradley's leadership will play a pivotal role in advancing Bayer's presence and growth in Thailand, particularly in the healthcare and agriculture sectors.
Published on 03/11/2023
» The WBCSD's Reporting Matters 2023 campaign meticulously analyses sustainability reports from 250 global companies, evaluating their overall performance based on transparency and the effectiveness of sustainability efforts. Charoen Pokphand Group has secured this prestigious recognition for the second consecutive year, thanks to sustainability reports that comprehensively outline agendas, strategies, and an emphasis on stakeholder engagement.
Published on 27/03/2023
» The Swiss Embassy in Thailand, led by H.E. Mr. Pedro Zwahlen, Ambassador of Switzerland to the Kingdom of Thailand, in collaboration with Novartis (Thailand) Limited, hosted a seminar under the theme “Reverse the Heart, Restore Your Life: Every Beat Matters.”
Published on 09/03/2023
» According to the Ministry of Public Health, 84,073 Thais die every year from cancer (1), with breast cancer being the most common among Thai women. Recurrence of and metastatic breast cancer often discourages patients from getting treatment as many women remain unaware that with early detection, diagnosis and appropriate treatment at early stage, cancer patients can have a better quality of life and spend longer time with their loved ones.
Business, Published on 07/06/2022
» Businesses adopted cost reduction, increased productivity, and emphasised environmental standards to cope with the pandemic and global challenges stemming from the Russia-Ukraine war, panellists told the Forbes Thailand 2022 Forum on Monday.
Oped, Published on 30/07/2021
» Names of medicines, vaccines and pharmaceutical companies have seeped into daily conversations. In the past, people cared so little about exact names of vaccines, injections or pills that they were given, not to mention details of manufacturer or even their locations. That has all changed thanks to the Covid-19 pandemic, which has triggered a shift in medication-taking behaviours. Names of the world's largest pharmaceutical companies, most of which are concentrated in the United States, followed by China, Japan, and European countries, have become more widely known, with the most familiar being Roche, Novartis, Merck, and Bristol Myers Squibb.
Asia focus, Published on 05/08/2019
» Virtually every country worldwide has committed to achieving universal health coverage (UHC) by 2030, as part of the United Nations Sustainable Development Goals. But some countries are progressing much faster than others in delivering equitable access not only to health services, but also to affordable medicines and vaccines. Among those leading the pack is Vietnam.